Prot# X05195: A Phase I/II Trial of Combined Weekly Bortezomib (VELCADE®) and Y-90-Ibritumomab Tiuxetan (Zevalin) in Patients with Relapsed or Refractory Follicular Lymphoma (NU Prot# NU 05H9)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/23/0610/1/18

Funding

  • Millennium Pharmaceuticals, Inc (X05195)